LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) FCF Margin Growth (3y) (2019 - 2026)

Analysis

LivaNova (LIVN) FCF Margin Growth (3y) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 884.00
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 503.00
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 646.00
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 534.00
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 919.00
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 3,472.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 353.00
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -97.00
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 60.00
10 LivaNova 4.51 Bn 3.99 Bn 273.67 Mn 1,700.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,700.00
Mar 31, 2026 -471.00
Dec 31, 2025 1,042.00
Sep 30, 2025 566.00
Jun 30, 2025 1,999.00
Mar 31, 2025 -442.00
Dec 31, 2024 1,163.00
Sep 30, 2024 216.00
Jun 30, 2024 252.00
Mar 31, 2024 -333.00
Dec 31, 2023 195.00
Sep 30, 2023 406.00
Jun 30, 2023 755.00
Mar 31, 2023 5,226.00
Dec 31, 2022 523.00
Sep 30, 2022 4,246.00
Jun 30, 2022 238.00
Mar 31, 2022 1,008.00
Dec 31, 2021 689.00
Sep 30, 2021 -625.00